Copyright
©The Author(s) 2017.
World J Gastroenterol. Jan 21, 2017; 23(3): 382-405
Published online Jan 21, 2017. doi: 10.3748/wjg.v23.i3.382
Published online Jan 21, 2017. doi: 10.3748/wjg.v23.i3.382
Physiological functions |
Store fat and retinoids in their perinuclear droplets, expressing GFAP, desmin and vimentin |
Secrete MMPs and TIMPs |
Maintains ECM turnover |
Involved in maintenance of pancreatic tissue architecture |
No or limited secretion of cytokines, chemokines and growth factors |
Function as an immune, progenitor and intermediary cell |
Possible role in exocrine and endocrine secretions |
Pathological functions |
Exhibit cell proliferation and migration |
Deranged ECM turnover due to loss of balance between MMPs and TIMPs |
Secrete various cytokines, chemokines and growth factors and thereby contribute to inflammatory milieu |
Stimulate cancer cell proliferation and migration and inhibit their apoptosis |
Mediate invasion and metastasis of carcinoma cells |
Mediate chemoresistance and radioresistance thereby promoting cancer cell survival |
Contribute to the hypovascular and hypoxic tumour microenvironment |
Promote angiogenesis, neural invasion and epithelial-mesenchymal transition |
Ref | Agent | Class/type of agent | In vivo/in vitro (study) model | Outcome of the study |
Nakamura et al[169] 2000 | FOY-007 FOY-305 | Synthetic serine protease inhibitor | Cytokine stimulated human periacinar fibroblast like cells | Both attenuated proliferation and procollagen type I C-terminal peptide (PIP) |
FOY-007 also inhibited collagen synthesis | ||||
Xie et al[170] 2002 | IS-741 | Carboxamide derivative | Wistar Bonn/Kobori rats | Suppressed the expression of IL-6 and CINC and pancreatic acute phase proteins (PAP and p8) |
Kuno et al[171] 2003 | Lisinopril | Angiotensin-converting enzyme (ACE) inhibitor | Wistar Bonn/Kobori rats | Increased pancreatic weight and decreased pancreatic MPO and serum ACE activity was observed |
Decrease in serum MCP-1 levels, intra-pancreatic hydroxyproline content was identified | ||||
TGF-β1 mRNA overexpression was suppressed | ||||
Yamada et al[172] 2003 | Candesartan | Angiotensin II receptor antagonist | Wistar Bonn/Kobori rats | Increased pancreatic weight and expression of angiotensinogen and angiotensin II receptor type 2 mRNA |
Decreased pancreatic MPO and serum ACE activity and hydroxyl proline content | ||||
Suppressed TGF-β1 mRNA overexpression | ||||
Masamune et al[173] 2003 | Y-27632 and HA-1077 | Rho kinase inhibitors | Isolated PSCs from male Wistar rats | Inhibited α-SMA expression, proliferation, type I collagen production and chemotaxis |
Nagashio et al[174] 2004 | AdTb-ExR | Adenoviral vector system expressing TGF-β receptor | Caerulein induced CP in BALB/c mice | Reduced the activated PSCs, number of apoptotic acinar cells and fibrosis |
Weight of the pancreas increased | ||||
Zhao et al[175] 2005 | Mutant MCP-1 | … | DBTC induced CP in Lewis rats | Decreased MCP-1, fibrosis and hydroxyproline levels |
Reduced IL6, TGF-β, IL-1β, MCP-1 and PDGF expression | ||||
Gibo et al[176] 2005 | Camostat mesilate | Oral protease inhibitor | In vivo: DBTC induced CP in Lewis rat In vitro: Culture activated PSCs | In vivo: Inflammation, fibrosis and cytokines expression was inhibited |
In vitro: PSC proliferation and MCP-1 production was reduced | ||||
Yamada et al[177] 2005 | Lisinopril and candesartan | Angiotensin-converting enzyme inhibitor and angiotensin II type 1 receptor blocker | Wistar Bonn/Kobori rats | Reduced MPO activity, hydroxyproline content, inflammation and fibrosis in combination therapy |
Suppressed mRNA expression of TGF-β1, PDGF- β and TNF-α | ||||
van Westerloo et al[178] 2005 | Troglitazone | PPAR-γ ligand | Caerulein induced experimental CP in female C57BL6 mice | Intrapancreatic fibrosis and hydroxy proline contents were reduced |
Attenuated increase in MPO content and TGF-β1 levels | ||||
Reding et al[179] 2006 | Rofecoxib | COX-2 inhibitor | Wistar Bonn/Kobori rats | Reduced TGF-β, collagen synthesis, inflammation and macrophage infiltration |
Asaumi et al[180] 2006 | Epigallocatechin-3-gallate EGCG | Antioxidant of polyphenols | Ethanol stimulated PSCs isolated from Wistar rats | Inhibited lipid peroxidation, SOD activity and p38 phosphorylation |
Decreased TGF-β1 and collagen secretion | ||||
Baumert et al[181] 2005 Fitzner et al[182] 2006 | IFN-γ | Antifibrotic cytokine | Culture activated PSCs, isolated from LEW.1W rats and pancreatic stellate cell lines | Diminished PSC proliferation and collagen synthesis |
Inhibited α-SMA expression | ||||
Induction of quiescent phenotype mediated through activated STAT1 | ||||
Ohashi et al[183] 2006 | Thioredoxin-1 (TRX-1) | Redox-regulating protein with antioxidative activity | Caerulein induced CP in wild type C57BL/6 mice and transgenic mice overexpressing TRX-1 | Attenuated PSC activation and fibrosis |
TGF-β1 and PDGF expression was reduced | ||||
Lower levels of MCP-1 in serum and acinar cells | ||||
McCarroll et al[184] 2006 | Retinol and its metabolites | Vitamers of vitamin A | Ethanol stimulated culture activated rat PSCs | Inhibited PSC activation, proliferation, expression of collagen I. All MAP kinases were activated |
Tasci et al[185] 2007 | Allopurinol | Xanthine oxidase inhibitor | Trinitrobenzene sulfonic acid (TNBS) induced CP in Sprague-Dawley rats | PSC activation was inhibited in vivo |
Lower collagen deposition and lobular and sub-lobular atrophy was observed | ||||
Lu et al[186] 2007 | Ascorbic acid | Antioxidant | DBTC induced CP in Sprague-Dawley rats | Decreased malondialdehyde (MDA), hyaluronic acid, laminin concentrations and pancreatic injury |
Increased superoxide dismutase activity | ||||
Shirahige et al[187] 2007 | Taurine | Amino sulfonic acid | DBTC induced pancreatic fibrosis in Wistar rats Culture activated PSCs from Wistar rats | Improved pancreatic fibrosis in rats. Increased IL-6 and decreased IL-2 were observed in pancreatic tissue homogenates |
PSC culture supernatants showed decreased type I collagen, MMP-2 and TGF-β1 | ||||
Rickmann et al[188]2007 | Tocotrienols | Vitamin E family members | Culture activated PSCs isolated from Wistar rats | Reduced viability of activated PSCs by apoptosis and autophagy |
Michalski CW et al[189] 2008 | Canabinoid WIN 55,212-2 | Aminoalkylindole derivative | Human PSCs from CP tissues | Reduced fibronectin, collagen1 and α-SMA levels |
Decreased IL-6, MCP-1 and MMP-2 secretion and invasiveness by PSCs | ||||
Weylandt et al[190] 2008 | Omega-3 polyunsaturated fatty acids (n-3 PUFA ) | Polyunsaturated fats | Caerulein-induced CP in fat-1 transgenic mice | Increased n-3 PUFA tissue levels |
Decreased PSC activation | ||||
Less pancreatic fibrosis and collagen content | ||||
Karatas et al[191] 2008 | Halofuginone | Synthetic halogenated derivative of febrifugine | Complete pancreatic duct obstruction and caerulein hyperstimulation in female Wistar rats | Lower serum amylase, lipase, hyaluronic acid, nitric oxide levels and tissue hydroxyproline levels |
Pancreatic inflammation and acinar cell atrophy was reduced | ||||
Fitzner et al[192] 2008 | Bosentan | ET-1-receptor antagonist | Culture activated rat PSCs | Inhibited PSC proliferation and collagen synthesis |
Reduced the expression of ET-1, α-SMA and CTGF | ||||
Schwer et al[193] 2010 | Carbon monoxide-releasing molecules-2 (CORMs) | Metal carbonyl compounds delivering carbon monoxide | Culture activated PSCs isolated from Wistar rats | PSC proliferation was inhibited through p38/HO-1 pathway activation |
Nathan et al[194] 2010 | Pancreatic secretory trypsin inhibitor (PSTI) | Caerulein induced CP in C57Bl/6 PSTI transgenic mice | Decreased MPO activity and inflammatory cell infiltration | |
Reduction in collagen I and fibronectin mRNA levels | ||||
González et al[195] 2011 | Palm oil tocotrienol-rich fraction | Vitamin E family members | Arginine induced chronic like pancreatitis in Wistar rats | Reduced amylase, hydroxyproline and TGF-β1 levels were observed |
Diminished α-SMA, fibronectin and collagen expression was identified | ||||
Long et al[196] 2011 | Octreotide | Analog of somatostatin | In vivo: PSC induced Pancreas Graft Fibrosis in Rats (Sprague Dawley rats as donors and Wistar rats as recipients) In vitro: PSCs isolated from Sprague Dawley rats | In vivo: Reduced inflammatory cell infiltration and expression of α-SMA, collagen I and TGF-β1 |
In vitro: PSC proliferation and activation was inhibited | ||||
Li et al[197] 2011 | Pancreatic stone protein ⁄ regenerating protein | Secretory stress proteins family | Culture activated PSCs from human CP tissue obtained by outgrowth method | Inhibited PSC proliferation, migration and reduced. collagen I and fibronectin |
Increased MMP/TIMP ratio and promoted fibrolysis | ||||
Tang et al[198] 2011 | Sinisan | Chinese herb | TNBS induced CP in Sprague-Dawley rats | Decreased serum amylase |
mRNA expression of TNF-α, IL-1β and COX-2 were reduced and IL-10 was increased | ||||
α-SMA expression was reduced | ||||
Wei et al[199] 2011 | Pravastatin | Competitive inhibitor of HMG-CoA | Pancreatic ductal hypertension induced CP in Wistar rats | Attenuated fibrosis and mRNA levels of TNF-α and TGF-β1 and increased IL-10 expression |
Exocrine secretion was improved | ||||
SOD activity was increased | ||||
Li et al[200] 2011 | α-Tocopherol | Vitamin E family member | TNBS induced CP in Sprague-Dawley rats | Reduced fibrosis and enhanced survival rate |
Pancreatic weight was increased in CP model | ||||
Monteiro et al[201] 2012 | Vitamin E supplementation | Ethanol induced (alcoholic) CP in Wistar rats | mRNA levels of α-SMA, COX-2, IL-6, MIP-3α and TNF-α were decreased and PAP was increased | |
Matsushita et al[202] 2012 | Taurine | Amino sulfonic acid | In vivo: DBTC induced CP in Wistar rats In vitro: AR42J acinar cells | Inhibited acinar cell apoptosis |
Yang et al[203] 2012 | L-Cysteine | Amino acid | In vivo: TNBS induced CP in Sprague-Dawley rats In vitro: Culture activated PSCs | Decreased α-SMA, TIMP-1, IL-1β TGF-β1 expression and hydroxylproline levels and increased MMP-2 levels |
Suppressed PSC proliferation and ECM synthesis | ||||
Bai et al[204] 2012 | Sulindac | Non-steroidal anti-inflammatory drug | Caerulein induced CP in C57BL/6 mice | Reduced fibrosis, acinar cell loss and inflammatory cell infiltration |
TNF-α and MCP-1 levels were decreased | ||||
Expression of TGF-β, PDGF-β, SHH and Gli was reduced | ||||
Lee et al[205] 2012 | Simvastatin and Troglitazone | HMG-CoA reductase inhibitor and PPAR agonists | Culture activated PSCs isolated from Sprague-Dawley rats | PSC proliferation was inhibited synergistically |
Shen et al[206] 2013 | rCXCL9 | Chemokine | In vivo: TNBS induced CP in Sprague-Dawley rats In vitro: Culture activated PSCs from Sprague-Dawley rats | In vivo: reduced fibrosis |
In vitro: protein expression of collagen 1α1 and TGF-β1 decreased | ||||
Gao et al[207] 2013 | Bone morphogeneic proteins | TGF-β superfamily members, | In vivo: Caerulein induced CP in female Swiss Webster mice In vitro: PSCs isolated from female Swiss Webster mice and human pancreatic tissue | In vivo: BMP2 protein levels were increased |
In vitro: PSC pre-treatment with BMP2 attenuated TGF-β1, α-SMA, fibronectin and collagen type Iα expression | ||||
Zhou et al[208] 2013 | Edaravone | Free radical scavenger | DBTC induced CP in Sprague-Dawley rats | Rats body weight was improved and reduced the fibrosis |
SOD activity was increased and MDA levels were decreased | ||||
TGF-β, TNF-α and IL-6 levels were downregulated | ||||
NF-κB and PSC activation was inhibited | ||||
Niina et al[209] 2014 | ONO-1301 | Prostacyclin agonist, | DBTC induced CP in Lewis rats | Reduced interstitial fibrosis and inflammatory cell infiltration |
Increased HGF and decreased IL-1β, TNF-α, TGF-β, MCP-1 and collagen mRNA expression was observed | ||||
Mrazek et al[210] 2015 | Apigenin | Hydroxyflavone | In vivo: Caerulein induced pancreatitis in C57/BL6 mice In vitro: PSCs isolated from human pancreatic tissues | In vivo: Reduced pancreatic fibrosis and retained acinar cell morphology |
In vitro: Induced PSC apoptosis and death | ||||
Downregulated the parathyroid hormone related protein induced fibronectin, collagen 1α1, PCNA, TGF-β and IL-6 expression | ||||
Tsang et al[211] 2015 | Trans-resveratrol | Natural stilbenoid | Rat pancreatic stellate cell line LTC-14 | Collagen type I, α-SMA and fibronectin was downregulated both at mRNA and protein level |
NF-κB activation was decreased | ||||
Lin et al[212] 2015 | Rhein, Emodin, and Curcumin | Phenolic compounds | Rat pancreatic stellate cell line LTC-14 | Collagen type I, α-SMA and fibronectin expression was decreased |
Gundewar et al[213] 2015 | L49H37 | Curcumin analog | Immortalized human pancreatic stellate cell line | Inhibited PSC proliferation and promoted apoptosis |
Decreased the phosphorylation of ERK1/2 | ||||
Tsang et al[214] 2015 | Eruberin A | Flavanol glycoside | Rat PSC line LTC-14 | Inhibited expression of α-SMA Collagen type I and fibronectin. Reduced the activation of NF-κB and phosphorylation PI3K/AKT |
Bläuer et al[215] 2015 | 1,25-dihydroxyvitamin D3 | Vitamin D metabolite | PSCs isolated from C57BL6JOlaHsd mouse | Antiproliferative and antifibrotic effects were observed |
Xiao et al[216] 2015 | Retinoic acid | Vitamin A Metabolite | In vivo: Caerulein induced CP in Balb/c mice In vitro: Culture activated PSCs | Decreased expression of TGF-βRII, collagen 1α1 PDGF-Rβ and β-catenin |
Nuclear translation of β-catenin was decreased | ||||
Wnt 2 and β-catenin protein expression was downregulated | ||||
Inhibited PSC proliferation and induced apoptosis | ||||
Witteck et al[217] 2015 | Trametinib and dactolisib | MEK inhibitor and PI3kinase/mTOR inhibitor | Culture activated PSCs isolated from Lewis rats | Both drugs inhibited PSC proliferation |
Trametinib suppressed the expression of IL-6 and TGF-β1 | ||||
Dactolisib decreased the levels of α-SMA and Collagen type Iα1 | ||||
Ulmasov et al[218] 2016 | CWHM-12 (RGD peptidomimetic compound) | Integrin inhibitor | In vivo: Caerulein induced pancreatitis in C57/BL6 mice In vitro: Rat PSC line LTC-14 | Pancreatic fibrosis, acinar cell atrophy and loss was reduced |
Decreased the expression of TGF-β regulated genes and PSC activation |
Ref | Agent | Class/type of agent | In vivo/in vitro (study) model | Outcome of the study |
Feldmann et al[219] 2007 | Cyclopamine | Steroidal alkaloid | Orthotopic xenograft model | Inhibited cancer cell invasion and metastasis by suppressing hedgehog |
Diep et al[220] 2011 | Erlotinib RDEA119 and AZD6244 | EGFR tyrosine Kinase and MAP kinase inhibitors | In vitro: Pancreatic cancer cell lines In vivo: BxPC-3 and MIA PaCa-2 mice xenograft model | Inhibited cancer cell proliferation, EGF receptor signaling and induced apoptosis |
Suppressed tumour growth | ||||
Froeling et al[221] 2011 | ATRA, 9-cis-RA and 13-cis-RA | Metabolites of vitamin A | In vivo: LSL-KrasG12D/+;LSL-Trp53R172H/+;Pdx-1-Cre mice In vitro: AsPc1 and Capan1 pancreatic cancer cell lines, PS1 and other PSC cell lines | Retinoic acid induced PSC quiescence and decreased migration |
Decreased and induced proliferation and apoptosis of cancer cells | ||||
Chauhan et al[222] 2013 | Losartan | Angiotensin inhibitor | Orthotopic mice model | Reduced stromal collagen production, expression of TGF-β1, CCN2 and ET-1 |
Improved drug and oxygen delivery to tumour | ||||
Sun et al[223] 2013 | Curcumin | Phenolic compound | TGF-β1 stimulated PANC-1 cell line | Inhibited proliferation and promoted apoptosis |
Cancer cell invasion and migration was decreased | ||||
Edderkaoui et al[224] 2013 | Ellagic acid Embelin | Polyphenolic and benzoquinone phytochemical | Pancreatic cancer cells and PSCs | Induced apoptosis and inhibited proliferation |
NF-κB activity was decreased | ||||
Macha et al[225] 2013 | Guggulsterone | Plant polyphenol | CD18/HPAF and Capan1 cell clones | Inhibited growth and colony formation |
Induced apoptosis and arrested cell cycle | ||||
Decreased motility and invasion | ||||
Kozono et al[226] 2013 | Pirfenidone | Pyridone compound | In vivo: Orthotopic tumour mice Model In vitro: PSCs isolated from pancreatic tissue | In vivo: Reduced tumour growth, PSC proliferation and the deposition of collagen type I and periostin in tumours was decreased |
In vitro: Proliferation, invasiveness and migration of PSCs was inhibited | ||||
Guan et al[227] 2014 | Retinoic acid | Vitamin A derivative | Panc-1 and Aspc-1 cell lines Cancer associated fibroblasts | Reduced α-SMA, FAP and IL-6 expression |
Inhibited cancer cell migration and EMT | ||||
Gonzalez-Villasana et al[228] 2014 | Bisphosphonates and nab-paclitaxel | Monocyte-macrophage lineage inhibitors | In vitro: Human PSCs and cancer cell line In vivo: Orthotopic mice model | In vitro: Inhibited PSC activation, proliferation MCP-1 release and collagen 1 expression and induced apoptosis |
In vivo: Reduced tumour size, fibrosis, proliferation and increased apoptosis | ||||
Pomianowska et al[229] 2014 | Prostaglandin E2 (PGE2) | Lipid compound | Human PSCs isolated from resected pancreatic tumour tissue | IL-1β and EGF induced COX-2 expression, TGF-β induced collagen synthesis and PDGF induced PSC proliferation was inhibited |
Gong et al[230] 2014 | Nexrutine | Phytoceutical with COX-2 Inhibitor activity | In vitro: pancreatic cancer cell lines In vivo: BK5-COX-2 transgenic mice | In vitro: promoted cancer cell apoptosis and reduced their growth |
Suppressed COX-2 expression | ||||
In vivo: NF-κB and Stat3 activity and fibrosis was decreased | ||||
Yan et al[231] 2014 | Crizotinib | c-MET/HGF receptor and ALK tyrosine kinases inhibitor | In vitro: Human pancreatic cancer cell lines AsPC-1, PANC-1, MIA PaCa-2 and Capan-1 In vivo: Mouse xenograft model | In vitro: Growth and proliferation was inhibited |
Induced apoptosis | ||||
Inhibited ALK activity | ||||
In vivo: Inhibited angiogenesis, tumour growth and ALK activity | ||||
Zhang et al[232] 2014 | 5-Azacytidine | Cytidine analogue | Bxpc-3 cancer cell line | Inhibited cancer cell proliferation by suppressing Wnt/β-catenin signaling |
Wang et al[233] 2014 | miR-216a | microRNA | In vitro: Capan-2 and PANC-1 pancreatic cancer cell lines In vivo: BALB/c nude mice | In vitro: Inhibited cell growth and induced apoptosis |
Down regulated survivin and XIAP expression | ||||
In vivo: Inhibited xenograft tumour growth by suppressing JAK2/STAT3 signaling pathway | ||||
Kumar et al[234] 2015 | miR-let7b and GDC-0449 | microRNA and Hedgehog inhibitor | In vitro: Capan-1, HPAF-II, T3M4 and MIA PaCa-2 cell lines In vivo: Athymic nude mice bearing ectopic tumour | In vitro: Decreased cell proliferation and induced apoptosis via Gli dependent mechanism |
In vivo: Reduced tumour cell proliferation with increased apoptosis and tumour growth was inhibited | ||||
Petrova et al[235] 2015 | RU-SKI 43 | Hedgehog acyltransferase inhibitor | In vitro: Pancreatic cancer cell lines In vivo: Panc-1 xenograft mouse model | In vitro: Reduced cancer cell proliferation and Gli-1 activation through Smo independent signaling |
Decreased Akt and mTOR activity | ||||
In vivo: Tumour growth decreased | ||||
Massó-Vallés et al[236] 2015 | Ibrutinib | Tyrosine kinase inhibitor | Transgenic mouse and xenograft mice models | Reduced fibrosis and extended survival |
Zhou et al[237] 2015 | Zileuton | 5-LOX inhibitor | Pancreatic cancer SW1990 cell line | Induced apoptosis, decreased proliferation and expression of 5-lipoxygenase |
Lui et al[238] 2015 | Desferrioxamine, Di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone and Di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone | Thiosemicarbazones | In vitro: PANC-1 and MIAPaCa-2 In vivo: PANC-1 tumour xenograft mice | Activation of the non-receptor tyrosine kinase Src and cAbl was decreased in vitro and STAT3 activation was reduced in both in vivo and in vitro condition |
Khan et al[239] 2015 | Ormeloxifene | Nonsteroidal drug | Pancreatic cancer cell lines and PDAC xenograft mice | Inhibited cell proliferation, tumour stroma through SHH pathway and stromal cell infiltration |
Decreased collagen I expression | ||||
Restored the tumour-suppressor miR-132 expression | ||||
Liu et al[240] 2016 | Oridonin | Tetracycline diterpenoid compound | Aspc1, Bxpc3, Panc1 and SW1990 cell lines | Migration and EMT was inhibited by affecting Wnt/β-catenin signal events |
Haqq et al[241] 2016 | Gemcitabine with omega-3 polyunsaturated fatty acid emulsion, (LipidemTM) | Nucleoside analog | In vitro studies using pancreatic cancer cell lines Capan-1 and Panc-1 and PSC cell line; RLT-PSC | Drugs showed antiproliferative and anti-invasive effects |
Ji et al[242] 2016 | MMP2 responsive liposome loaded with Pirfenidone and gemcitabine | --- | In vivo: BALB/c nude Orthotopic tumour mice model In vitro: Human PSCs isolated from surgical specimens of Pancreatic cancer | Pirfenidone inhibited collagen I and TGF-β expression in PSCs |
Gemcitabine killed pancreatic tumour cells |
- Citation: Bynigeri RR, Jakkampudi A, Jangala R, Subramanyam C, Sasikala M, Rao GV, Reddy DN, Talukdar R. Pancreatic stellate cell: Pandora's box for pancreatic disease biology. World J Gastroenterol 2017; 23(3): 382-405
- URL: https://www.wjgnet.com/1007-9327/full/v23/i3/382.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i3.382